Kingfa Science FY26 net profit rises 21% to ₹18,525.85 lakh
Kingfa Science & Technology (India) Limited reported a 21.20% increase in net profit to ₹18,525.85 lakh for the financial year ended March 31, 2026, driven by a 14.40% rise in revenue from operations to ₹1,99,555.15 lakh. For the quarter ended March 31, 2026, net profit stood at ₹5,914.93 lakh, with Q4 EBITDA rising to 810M rupees and margins expanding to 14%. The Board approved the audited standalone financial results on May 29, 2026, and the results were published in The Financial Express and Makkal Kural on May 30, 2026, pursuant to Regulation 47 of the SEBI (LODR) Regulations, 2015.

*this image is generated using AI for illustrative purposes only.
Kingfa Science & Technology (India) Limited reported a 21.20% increase in net profit to ₹18,525.85 lakh for the financial year ended March 31, 2026, driven by higher revenue from operations. Revenue from operations for FY26 rose 14.40% to ₹1,99,555.15 lakh from ₹1,74,469.06 lakh in the previous year. Total income for the year increased to ₹2,01,619.89 lakh from ₹1,75,406.57 lakh in the prior year. The Board of Directors approved the audited standalone financial results for the quarter and year ended March 31, 2026, at a meeting held on May 29, 2026. Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the financial results were published in The Financial Express (English) and Makkal Kural (Tamil) on May 30, 2026.
For the quarter ended March 31, 2026, the company posted a net profit of ₹5,914.93 lakh, compared to ₹4,189.76 lakh in the corresponding quarter of the previous year. Revenue from operations for the quarter stood at ₹57,846.85 lakh, up from ₹46,955.28 lakh in the same period last year. On the profitability front, Q4 EBITDA rose to 810M rupees from 605M rupees year-on-year, with the EBITDA margin expanding to 14% from 12.87% in the same period last year, reflecting improved operational efficiency. The company's earnings per share (EPS) for the year improved to ₹144.10 from ₹126.22 in the previous year.
Financial Performance
The following table summarizes the key financial metrics for Kingfa Science & Technology (India) Limited for the quarter and year ended March 31, 2026:
| Particulars: | Q4 FY26 (₹ in Lakhs) | Q4 FY25 (₹ in Lakhs) | FY26 (₹ in Lakhs) | FY25 (₹ in Lakhs) |
|---|---|---|---|---|
| Revenue from Operations | 57,846.85 | 46,955.28 | 1,99,555.15 | 1,74,469.06 |
| Total Income | 58,561.62 | 47,148.15 | 2,01,619.89 | 1,75,406.57 |
| Total Expenses | 50,588.51 | 41,715.30 | 1,76,629.36 | 1,54,798.62 |
| Profit Before Tax | 7,973.11 | 5,432.85 | 24,990.53 | 20,607.95 |
| Net Profit | 5,914.93 | 4,189.76 | 18,525.85 | 15,285.52 |
The Q4 EBITDA performance is highlighted below:
| Metric: | Q4 FY26 | Q4 FY25 |
|---|---|---|
| EBITDA | 810M Rupees | 605M Rupees |
| EBITDA Margin | 14% | 12.87% |
Segment and Operational Details
Kingfa Science & Technology (India) Limited operates in a single reportable segment — the manufacture of Modified Thermoplastic Compounds — in accordance with Ind AS 108. The company does not have any subsidiary, associate, or joint venture companies as on March 31, 2026, and therefore the requirement to prepare consolidated financial results is not applicable. The statutory auditor, M/s. P G Bhagwat LLP, issued an audit report with an unmodified opinion on the financial results, which were reviewed by the Audit Committee on May 28, 2026, prior to Board approval. The trading window for dealing in the company's securities will remain closed until 48 hours after the declaration of the audited financial results, in accordance with the company's Code of Conduct for Prevention of Insider Trading.
Historical Stock Returns for Kingfa Science & Technology
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.57% | -0.58% | -2.81% | +26.50% | +66.46% | +405.10% |
What strategies will Kingfa Science & Technology implement to sustain the improved operational efficiency and EBITDA margin expansion in FY27?
How does the company plan to utilize the increased net profit and cash flow—will it focus on capacity expansion, debt reduction, or shareholder returns?
What are the projected demand trends for Modified Thermoplastic Compounds in the coming year, and how might global supply chain fluctuations impact revenue growth?

































